Barlesi F - Search Results

1

Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.

Riudavets M, Naigeon M, Texier M, Dorta M, Barlesi F, Mazieres J, Varga A, Cassard L, Boselli L, Grivel J, NgoCamus M, Lacroix L, Mezquita L, Besse B, Chaput N, Planchard D. Riudavets M, et al. Among authors: barlesi f. Lung Cancer. 2022 Apr;166:255-264. doi: 10.1016/j.lungcan.2021.11.018. Epub 2021 Dec 3. Lung Cancer. 2022. PMID: 34953624 Clinical Trial.

2

Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?

Greillier L, Barlési F, Doddoli C, Durieux O, Torre JP, Gimenez C, Kleisbauer JP. Greillier L, et al. Among authors: barlesi f. Respiration. 2004 Mar-Apr;71(2):178-83. doi: 10.1159/000076681. Respiration. 2004. PMID: 15031575

3

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.

Barlési F, Tchouhadjian C, Doddoli C, Torre JP, Astoul P, Kleisbauer JP. Barlési F, et al. Br J Cancer. 2005 Jan 17;92(1):13-4. doi: 10.1038/sj.bjc.6602296. Br J Cancer. 2005. PMID: 15597098 Free PMC article.

4

Biologic staging of non-small-cell lung cancer: prospect or proposal?

Barlesi F, Jacot W, Pujol JL. Barlesi F, et al. Clin Lung Cancer. 2005 Jan;6(4):225-6. doi: 10.1016/S1525-7304(11)70471-5. Clin Lung Cancer. 2005. PMID: 15694014 No abstract available.

5

Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials.

Barlési F, Pujol JL. Barlési F, et al. Lung Cancer. 2005 Sep;49(3):289-98. doi: 10.1016/j.lungcan.2005.03.034. Lung Cancer. 2005. PMID: 15913840

6

Second-line treatment for advanced non-small cell lung cancer: a systematic review.

Barlési F, Jacot W, Astoul P, Pujol JL. Barlési F, et al. Lung Cancer. 2006 Feb;51(2):159-72. doi: 10.1016/j.lungcan.2005.08.017. Epub 2005 Dec 19. Lung Cancer. 2006. PMID: 16360238 Review.

7

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.

Pujol JL, Barlesi F, Daurès JP. Pujol JL, et al. Among authors: barlesi f. Lung Cancer. 2006 Mar;51(3):335-45. doi: 10.1016/j.lungcan.2005.11.001. Epub 2006 Feb 14. Lung Cancer. 2006. PMID: 16478643

8

Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.

Barlési F, Tummino C, Tasei AM, Astoul P. Barlési F, et al. Lung Cancer. 2006 Dec;54(3):423-5. doi: 10.1016/j.lungcan.2006.06.021. Epub 2006 Oct 17. Lung Cancer. 2006. PMID: 17049669

9

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.

LeCaer H, Barlesi F, Robinet G, Fournel P, Geriniere L, Bombaron P, Falchero L, Auliac JB, Crequit J, Chouaid C. LeCaer H, et al. Among authors: barlesi f. Lung Cancer. 2007 Jul;57(1):72-8. doi: 10.1016/j.lungcan.2007.02.012. Epub 2007 Mar 27. Lung Cancer. 2007. PMID: 17391803 Clinical Trial.

10

Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.

Breen D, Barlési F, Zemerli M, Doddoli C, Torre JP, Thomas P, Astoul P. Breen D, et al. Among authors: barlesi f. Clin Lung Cancer. 2007 Mar;8(5):331-4. doi: 10.3816/CLC.2007.n.013. Clin Lung Cancer. 2007. PMID: 17562233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page